BETHANY MARTIN: Open Payments
NPI 1750999231 · BOLIVAR, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,857 in 124 payments from 40 companies in 2025. Trend: 2023 $4,202 · 2024 $3,325 · 2025 $2,857
Food & beverage: $2,857
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $289 |
| Novartis Pharmaceuticals Corporation | 13 | $231 |
| ABBVIE INC. | 9 | $209 |
| Medtronic, Inc. | 1 | $169 |
| E.R. Squibb & Sons, L.L.C. | 10 | $162 |
| Janssen Biotech, Inc. | 10 | $160 |
| Novocure Inc. | 1 | $133 |
| Dendreon Pharmaceuticals LLC | 4 | $105 |
| GlaxoSmithKline, LLC. | 5 | $99 |
| Celgene Corporation | 5 | $96 |
Products named: ENHERTU, OSTEOCOOL RF ABLATION SYSTEM, IMBRUVICA, SCEMBLIX, Optune Lua (NovoTTF-200T), REBLOZYL, PROVENGE, OPDIVO.
Industry payments across MO — which companies pay providers there.
